Response inhibition and serotonin in autism: A functional MRI study using acute tryptophan depletion

Brain

Volumn 137, Issue 9, 2014, Pages 2600-2610

  Daly, Eileen ^a   Ecker, Christine ^a   Hallahan, Brian ^b   Deeley, Quinton ^a   Craig, Michael ^a   Murphy, Clodagh ^a   Johnston, Patrick ^a   Spain, Debbie ^a   Gillan, Nicola ^a   Gudbrandsen, Maria ^a   Brammer, Michael ^a   Giampietro, Vincent ^a   Lamar, Melissa ^c   Page, Lisa ^d   Toal, Fiona ^a   Schmitz, Nicole ^e   Cleare, Anthony ^a   Robertson, Dene ^f   Rubia, Katya ^a   Murphy, Declan G M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d SUSSEX PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Autistic spectrum disorder; Impulsivity and inhibition disorders

Indexed keywords

SEROTONIN; TRYPTOPHAN;

ADULT; AUTISM; BRAIN FUNCTION; CAUDATE NUCLEUS; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPLETION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG INHIBITION; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INTELLIGENCE; MALE; MODULATION; PRIORITY JOURNAL; REVIEW; THALAMUS; TRYPTOPHAN DEPLETION;

AUTISTIC SPECTRUM DISORDER; IMPULSIVITY AND INHIBITION DISORDERS;

ADOLESCENT; ADULT; AUTISTIC DISORDER; BRAIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEURAL INHIBITION; PHOTIC STIMULATION; REACTION TIME; SEROTONIN; TRYPTOPHAN; YOUNG ADULT;

EID: 84906707662     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awu178     Document Type: Review

References (63)

1. Abell F, HappéF, Frith U. Do triangles play tricks? Attribution of mental states to animated shapes in normal and abnormal development. Cogn Dev 2000; 15: 1-16.
2. Anderson IM, Clark L, Elliott R, Kulkarni B, Williams SR, Deakin JFW. 5-HT2C receptor activation by m-chlorophenylpiperazine detected in humans with functional MRI. Neuroreport 2002; 13: 1547-51.
3. Anderson BM, Schnetz-Boutaud NC, Bartlett J, Wotawa AM, Wright HH, Abramson RK, et al. Examination of association of genes in the serotonin system to autism. Neurogenetics 2009; 10: 209-16.
4. Autism and Developmental Disabities Monitoring Network Surveillance Year. 2008, Principal Investigators C. Prevalence of Autism Spectrum Disorders-Autism and Developmental Disabilites Monitoring Network, 14 Sites, Morbidity and mortality weekly report 2012. p. 1-19.
5. Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The autism-spectrum quotient (AQ): evidence from Asperger Syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord 2001; 31: 603.
6. Beck AT, Brown G, Epstein N, Steer RA. An inventory for measuring clinical anxiety - psychometric properties. J Consult Clin Psychol 1988; 56: 893-7.
7. Beck AT, Steer RA. Manual for the beck depression inventory. San Antonio, TX: Psychological Corporation; 1993.
8. Clark L, Roiser J, Cools R, Rubinsztein D, Sahakian B, Robbins T. Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology 2005; 182: 570-8.
9. Cook EH Jr, Leventhal BL. The serotonin system in autism. Curr Opin Pediatr 1996; 8: 348-54.
10. Cook EH, Charak DA, Arida J, Spohn JA, Roizen NJM, Leventhal BL. Depressive and obsessive-compulsive symptoms in hyperserotonemic parents of children with autistic disorder. Psychiatry Res 1994; 52: 25-33.
11. Chambers CD, Garavan H, Bellgrove MA. Insights into the neural basis of response inhibition from cognitive and clinical neuroscience. Neurosci Biobehav Rev 2009; 33: 631-46.
12. Chamberlain SR, Muller U, Blackwell AD, Clark L, Robbins TW, Sahakian BJ. Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 2006; 311: 861-3.
13. Chugani DC, Muzik O, Rothermel R, Behen M, Chakraborty P, Mangner T, et al. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol 1997; 42: 666-9.
14. Coghlan S, Horder J, Inkster B, Mendez MA, Murphy DG, Nutt DJ. GABA system dysfunction in autism and related disorders: from synapse to symptoms. Neurosci Biobehav Rev 2012; 36: 2044-55.
15. Crockett MJ, Clark L, Robbins TW. Reconciling the role of serotonin in behavioral inhibition and aversion: acute tryptophan depletion abolishes punishment-induced inhibition in humans. J Neurosci 2009; 29: 11993-9.
16. Del-Ben CM, Deakin JFW, McKie S, Delvai NA, Williams SR, Elliott R, et al. The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an functional MRI study. Neuropsychopharmacology 2005; 30: 1724-34.
17. Devlin B, Cook EH, Coon H, Dawson G, Grigorenko EL, McMahon W, et al. Autism and the serotonin transporter: the long and short of it. Mol Psychiatry 2005; 10: 1110-6.
18. Daly E, Deeley Q, Ecker C, Craig M, Hallahan B, Murphy C, et al. Serotonin and the neural processing of facial emotions in adults with autism: an fmri study using acute tryptophan depletion. Arch Gen Psychiatry 2012; 69: 1-11.
19. Daly E, Deeley Q, Hallahan B, Craig M, Brammer M, Lamar M, et al. Effects of acute tryptophan depletion on neural processing of facial expressions of emotion in humans. Psychopharmacology 2010; 210: 499-510.
20. D'Eufemia P, Finocchiaro R, Celli M, Viozzi L, Monteleone D, Giardini O. Low serum tryptophan to large neutral amino acids ratio in idiopathic infantile autism. Biomed Pharmacother 1995; 49: 288-92.
21. Eagle D, Bari A, Robbins T. The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology 2008; 199: 439-56.
22. Fernstrom JD. Role of the precursor availability in control of monoamine biosyntesis in brain. Physiol Rev 1983; 63: 484-546.
23. Foa EB, Huppert JD, Leiberg S, Langner R, Kichic R, Hajcak G, et al. The obsessive-compulsive inventory: development and validation of a short version. Psychol Assess 2002; 14: 485-96.
24. Friedman SDPS, Artru AA, Richards TL, Gardner J, Dawson G, Posse S, et al. Regional brain chemical alterations in young children with autism spectrum disorder.[article]. Neurology 2003; 60: 100-7.
25. Hill EL. Evaluating the theory of executive dysfunction in autism. Dev Rev 2004; 24: 189-233.
26. Hollander E, Novotny S, Allen A, Aronowitz B, Cartwright C, DeCaria C. The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder. Neuropsychopharmacology 2000; 22: 163-7.
27. Hollander E, Soorya L, Chaplin W, Anagnostou E, Taylor BP, Ferretti CJ, et al. A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult Autism spectrum disorders. Am J Psychiatry 2012; 169: 292-9.
28. Hranilovic D, Bujas-Petkovic Z, Tomicic M, Bordukalo-Niksic T, Blazevic S, Cicin-Sain L. Hyperserotonemia in autism: activity of 5HT-associated platelet proteins. J Neural Transm 2009; 116: 493-501.
29. Kana RK, Keller TA, Minshew NJ, Just MA. Inhibitory control in highfunctioning autism: decreased activation and underconnectivity in inhibition networks. Biol Psychiatry 2007; 62: 198-206.
30. Keating J, Dratcu L, Lader M, Sherwood RA. Measurement of plasma serotonin by high-performance liquid chromatography with electrochemical detection as an index of the in vivo activity of fluvoxamine. J Chromatogr Biomed Appl 1993; 615: 237-42.
31. King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, et al. Lack of efficacy of citalopram in children with Autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with Autism. Arch Gen Psychiatry 2009; 66: 583-90.
32. Lamar M, Cutter WJ, Rubia K, Brammer M, Daly EM, Craig MC, et al. 5-HT, prefrontal function and aging: functional MRI of inhibition and acute tryptophan depletion. Neurobiol Aging 2009; 30: 1135-46.
33. Langen M, Kas MJH, Staal WG, van Engeland H, Durston S. The neurobiology of repetitive behavior: of mice. Neurosc Biobehav Rev 2011; 35: 345-55.
34. Langen M, Leemans A, Johnston P, Ecker C, Daly E, Murphy CM, et al. Fronto-striatal circuitry and inhibitory control in autism: findings from diffusion tensor imaging tractography. Cortex 2012; 48: 183-93.
35. Leboyer M, Philippe A, Bouvard M, Guilloud-Bataille M, Bondoux D, Tabuteau F, et al. Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biol Psychiatry 1999; 45: 158-63.
36. Liddle PF, Kiehl KA, Smith AM. Event-related functional MRI study of response inhibition. Hum Brain Mapp 2001; 12: 100-9.
37. Lord C, Rutter M, Lecouteur A. Autism Diagnostic Interview-Revised-A revised version of a diagnostic Interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994; 24: 659-85.
38. Lord C, Rutter M, DiLavore P, Risi S, Gotham K, Bishop S. Autism diagnostic observation schedule, Second Edition (ADOS-2) Manual (Part 1: Modules 1-4). Torrance, CA: Western Psychological Services. 2012.
39. Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Mawhood L, et al. Austism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord 1989; 19: 185-212.
40. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry 1998; 44: 151-62.
41. McAlonan GM, Daly E, Kumari V, Critchley HD, van Amelsvoort T, Suckling J, et al. Brain anatomy and sensorimotor gating in Asperger's syndrome. Brain 2002; 125: 1594-606.
42. McEwen BS, Chattarji S, Diamond DM, Jay TM, Reagan LP, Svenningsson P, et al. The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Mol Psychiatry 2009; 15: 237-49.
43. Murphy DGM, Daly E, Schmitz N, Toal F, Murphy K, Curran S, et al. Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study. Am J Psychiatry 2006; 163: 934-6.
44. Nakamura K, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M, et al. Brain serotonin and dopamine transporter bindings in adults with high-functioning Autism. Arch Gen Psychiatry 2010; 67: 59-68.
45. Otsuka H, Harada M, Mori K, Hisaoka S, Nishitani H. Brain metabolites in the hippocampus-amygdala region and cerebellum in autism: an HMR spectroscopy study. Neuroradiology 1999; 41: 517-9.
46. Pazos A, Probst A, Palacios JM. Serotonin receptors in the human brain- III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 1987; 21: 97-122.
47. Piven J, Tsai G, Nehme E, Coyle J, Chase G, Folstein S. Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord 1991; 21: 51-9.
48. Robbins TW, Crockett MJ. Chapter 3.8- Role of central serotonin in impulsivity and compulsivity: comparative studies in experimental animals and humans. In: Christian PM, Barry LJ, editors. Handbook of the behavioral neurobiology of serotonin. Academic Press, London; 2010. p. 415-27.
49. Rubia K, Lee F, Cleare AJ, Tunstall N, Fu CH, Brammer M, et al. Tryptophan delpetion reduces right inferior prefrontal activation during response inhibition in fast, event-related functional MRI. Psychopharmacology 2005; 179: 791-803.
50. Rubia K, Smith AB, Taylor E, Brammer M. Linear age-correlated functional development of right inferior fronto-striato-cerebellar networks during response inhibition and anterior cingulate during error-related processes. Hum Brain Mapp 2007; 28: 1163-77.
51. Sambeth A, Blokland A, Harmer CJ, Kilkens TOC, Nathan PJ, Porter RJ, et al. Sex differences in the effect of acute tryptophan depletion on declarative episodic memory: a pooled analysis of nine studies. Neurosci Biobehav Rev 2007; 31: 516-29.
52. Schmitz N, Rubia K, Daly E, Smith AB, Williams SC, Murphy DGM. Neural correlates of executive function in autistic spectrum disorders. Biol Psychiatry 2006; 59: 7-16.
53. SoubriéP. Reconciling the role of central serotonin neurons in human and animal behavior. Behav Brain Sci 1986; 9: 319-35.
54. Thirion B, Pinel P, Meriaux S, Roche A, Dehaene S, Poline J-B. Analysis of a large functional MRI cohort: statistical and methodological issues for group analyses. Neuroimage 2007; 35: 105-20.
55. Varnäs K, Halldin C, Hall H. Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp 2004; 22: 246-60.
56. Vollm B, Richardson P, McKie S, Elliott R, Deakin JFW, Anderson IM. Serotonergic modulation of neuronal responses to behavioural inhibition and reinforcing stimuli: an functional MRI study in healthy volunteers. Eur J Neurosci 2006; 23: 552-60.
57. Wechsler D. Wechsler adult intelligence scale: WAIS-R. New York: Psychological Corporation; 1981.
58. Whitaker-Azmitia PM. Serotonin and brain development: role in human developmental diseases. Brain Res Bull 2001; 56: 479-85.
59. World Health Organization. The ICD-10 classification of mental and behavioural disorders : clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.
60. World Health Organization. The ICD-10 classification of mental and behavioural disorders : diagnostic criteria for research. Geneva: World Health Organization; 1993.
61. Young SN. Acute tryptophan depletion in humans: a review of theoretical, practical and ethical aspects. J Psychiatry Neurosci 2013; 38: 294-305.
62. Young SN, Ervin FR, Pihl RO, Finn P. Biochemical aspects of tryptophan depletion in primates. Psychopharmacology 1989; 98: 508-11.
63. Zafeiriou DI, Ververi A, Vargiami E. The Serotonergic system: its role in pathogenesis and early developmental treatment of autism. Curr Neuropharmacol 2009; 7: 150-7.